Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 330-337

  Li, Chunrong ^a   Iida, Mari ^a   Dunn, Emily F ^a   Wheeler, Deric L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cetuximab; Dasatinib; EGFR; Head and neck cancer; Radiation; Src family kinases

Indexed keywords

CETUXIMAB; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL NUCLEUS; COLON CANCER; DRUG POTENTIATION; GENE TRANSLOCATION; HEAD AND NECK CARCINOMA; LUNG CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; SRC HOMOLOGY DOMAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SQUAMOUS CELL; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PYRIMIDINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; THIAZOLES;

EID: 78149357809     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.06.010     Document Type: Article

References (27)

1. A. Citri, and Y. Yarden EGF-ErbB signalling: towards the systems level Nat Rev Mol Cell Biol 7 2006 505 516
2. U. Marti, S.J. Burwen, and A. Wells Localization of epidermal growth factor receptor in hepatocyte nuclei Hepatology 13 1991 15 20
3. H. Cao, Z.M. Lei, L. Bian, and C.V. Rao Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta Endocrinology 136 1995 3163 3172
4. S.Y. Lin, K. Makino, and W. Xia Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat Cell Biol 3 2001 802 808
5. H.W. Lo, S.C. Hsu, and M.C. Hung EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization Breast Cancer Res Treat 95 2006 211 218
6. H.W. Lo, and M.C. Hung Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival Br J Cancer 94 2006 184 188
7. H.W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.C. Hung Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res 65 2005 338 348
8. A. Psyrri, Z. Yu, and P.M. Weinberger Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis Clin Cancer Res 11 2005 5856 5862
9. W. Xia, Y. Wei, and Y. Du Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer Mol Carcinog 48 2009 610 617
10. H.W. Lo, S.C. Hsu, and M. Ali-Seyed Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway Cancer Cell 7 2005 575 589
11. S.C. Hsu, and M.C. Hung Characterization of a novel tripartite nuclear localization sequence in the EGFR family J Biol Chem 282 2007 10432 10440
12. H.W. Lo, X. Cao, H. Zhu, and F. Ali-Osman Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes Mol Cancer Res 8 2010 232 245
13. H.W. Lo, M. Ali-Seyed, Y. Wu, G. Bartholomeusz, S.C. Hsu, and M.C. Hung Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1 J Cell Biochem 98 2006 1570 1583
14. H.J. Liao, and G. Carpenter Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression Mol Biol Cell 18 2007 1064 1072
15. N. Hanada, H.W. Lo, C.P. Day, Y. Pan, Y. Nakajima, and M.C. Hung Co-regulation of B-Myb expression by E2F1 and EGF receptor Mol Carcinog 45 2006 10 17
16. L.Y. Hung, J.T. Tseng, and Y.C. Lee Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression Nucleic Acids Res 36 2008 4337 4351
17. S.C. Wang, Y. Nakajima, and Y.L. Yu Tyrosine phosphorylation controls PCNA function through protein stability Nat Cell Biol 8 2006 1359 1368
18. K. Dittmann, C. Mayer, R. Kehlbach, and H.P. Rodemann Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport, activation of DNA-PK Mol Cancer 7 2008 69
19. H.J. Liao, and G. Carpenter Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor Cancer Res 69 2009 6179 6183
20. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
21. C. Li, M. Iida, E.F. Dunn, A.J. Ghia, and D.L. Wheeler Nuclear EGFR contributes to acquired resistance to cetuximab Oncogene 28 2009 3801 3813
22. J.S. Biscardi, M.C. Maa, D.A. Tice, M.E. Cox, T.H. Leu, and S.J. Parsons C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function J Biol Chem 274 1999 8335 8343
23. K. Dittmann, C. Mayer, and H.P. Rodemann Inhibition of radiation-induced EGFR nuclear import by C225 (cetuximab) suppresses DNA-PK activity Radiother Oncol 76 2005 157 161
24. K. Dittmann, C. Mayer, and H.P. Rodemann Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function Strahlenther Onkol 186 2010 1 6
25. R. Mandic, C.J. Rodgarkia-Dara, and L. Zhu Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor FEBS Lett 580 2006 4793 4800
26. J.L. Boerner, M.L. Demory, C. Silva, and S.J. Parsons Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II Mol Cell Biol 24 2004 7059 7071
27. D.L. Wheeler, S. Huang, and T.J. Kruser Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members Oncogene 27 2008 3944 3956